Company / Depreciation & Amortization
Vera Therapeutics, Inc. Depreciation & Amortization History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$468.0K
FY2025
5-year range
$21.0K / $468.0K
FY2023-FY2025
Trend
+345.7%
vs FY2024
Sector context
#138 of 168
Health Care
What the data says
Depreciation & Amortization changed +346% YoY in FY2025, a notable deviation from the 2-year average annual change of +373%.
Based on SEC 10-K filings.
$468,000 in FY2025.
Increased from $21,000 to $468,000 over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 18% in Health CareTop 18% of 168This company $468.0K Sector average $212.9M
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, depreciation & amortization increased 345.7% year-over-year.
- Ranks #138 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $468.0K | +345.7% |
| FY2024 | $105.0K | +400.0% |
| FY2023 | $21.0K | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026